Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Electrocore Inc (ECOR)

Electrocore Inc (ECOR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,515
  • Shares Outstanding, K 48,544
  • Annual Sales, $ 3,500 K
  • Annual Income, $ -23,510 K
  • 60-Month Beta 1.29
  • Price/Sales 14.72
  • Price/Cash Flow N/A
  • Price/Book 1.76
Trade ECOR with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9200 +13.04%
on 07/26/21
1.2600 -17.46%
on 07/20/21
-0.1500 (-12.61%)
since 06/30/21
3-Month
0.9200 +13.04%
on 07/26/21
1.8500 -43.78%
on 06/08/21
-0.6600 (-38.82%)
since 04/30/21
52-Week
0.9200 +13.04%
on 07/26/21
3.6300 -71.35%
on 03/01/21
-0.5000 (-32.47%)
since 07/30/20

Most Recent Stories

More News
electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,065,444 to...

ECOR : 1.0400 (+1.96%)
electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th

electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter ended June 30, 2021 after the close of the market...

ECOR : 1.0400 (+1.96%)
electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience

electroCore, Inc. (the "Company"), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its cofounder and Chief Medical Officer, Dr. Peter Staats, is to receive a Lifetime...

ECOR : 1.0400 (+1.96%)
Thinking about buying stock in Cemtrex, Millendo Therapeutics, Exela Technologies, OrganiGram, or electroCore?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CETX, TPST, XELA, OGI, and ECOR.

CETX : 1.2800 (-2.29%)
XELA : 2.63 (+1.15%)
ECOR : 1.0400 (+1.96%)
OGI : 2.62 (-1.13%)
TPST : 15.02 (-2.97%)
electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, CEO will present a company overview and be available for 1x1 meetings at the following...

ECOR : 1.0400 (+1.96%)
Thinking about buying stock in Aerpio Pharmaceuticals, Gan, electroCore, Crexendo, or TESSCO Technologies?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARPO, GAN, ECOR, CXDO, and TESS.

ARPO : 2.02 (-4.72%)
CXDO : 6.00 (-2.09%)
ECOR : 1.0400 (+1.96%)
GAN : 15.30 (-1.29%)
TESS : 6.01 (+0.17%)
electroCore Announces Pricing of $18.0 Million Public Offering of Common Stock

electroCore, Inc. (the "Company"), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced the pricing of an underwritten public offering of 18,000,000 shares of its common stock...

ECOR : 1.0400 (+1.96%)
electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper on June 10, 2021, entitled "Effects of Transcutaneous Vagal...

ECOR : 1.0400 (+1.96%)
electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into an agreement with Kromax International Corporation to serve as the exclusive distributor...

ECOR : 1.0400 (+1.96%)
electroCore to Join Russell Microcap(R) Index

electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today the addition of its stock to the broad-market Russell Microcap Index after its 2021 annual reconstitution,...

ECOR : 1.0400 (+1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

electroCore Inc. is a commercial-stage bioelectronic medicine company. Its current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache. electroCore Inc., formerly known as ELECTROCORE LLC, is based in LOS ANGELES, CA....

See More

Key Turning Points

3rd Resistance Point 1.1133
2nd Resistance Point 1.0867
1st Resistance Point 1.0633
Last Price 1.0400
1st Support Level 1.0133
2nd Support Level 0.9867
3rd Support Level 0.9633

See More

52-Week High 3.6300
Fibonacci 61.8% 2.5948
Fibonacci 50% 2.2750
Fibonacci 38.2% 1.9552
Last Price 1.0400
52-Week Low 0.9200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar